▶주메뉴 바로가기

▶본문 바로가기

THE INVESTOR
April 22, 2018

Market Now

Feelux acquires US drug developers at W38b

  • PUBLISHED :April 16, 2018 - 12:04
  • UPDATED :April 16, 2018 - 12:04
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print
[DISCLOSURE] Feelux (033180) announced on April 13 that it has acquired 100 percent stakes in TJU Asset Management and Penn Life Science at 37.8 billion won (US$35.24 million). 

By Hwang You-mee (glamazon@heraldcorp.com)

  • facebook
  • twitter
  • sms
  • print

EDITOR'S PICKS